Antitumor Cell-Complex Vaccines Employing Genetically Modified Tumor Cells and Fibroblasts
The present study evaluates the immune response mediated by vaccination with cell complexes composed of irradiated B16 tumor cells and mouse fibroblasts genetically modified to produce GM-CSF. The animals were vaccinated with free B16 cells or cell complexes. We employed two gene plasmid constructio...
Main Authors: | Antonio Miguel, María José Herrero, Luis Sendra, Rafael Botella, Ana Diaz, Rosa Algás, Salvador F. Aliño |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-02-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/6/2/636 |
Similar Items
-
Comparative Antitumor Effect of Preventive versus Therapeutic Vaccines Employing B16 Melanoma Cells Genetically Modified to Express GM-CSF and B7.2 in a Murine Model
by: Salvador F. Aliño, et al.
Published: (2012-10-01) -
Bead-Selected Antitumor Genetic Cell Vaccines
by: Herrero Mj, et al.
Published: (2008-01-01) -
Multicompartmental Lipopolyplex as Vehicle for Antigens and Genes Delivery in Vaccine Formulations
by: Isaías Sanmartín, et al.
Published: (2021-02-01) -
Genotoxic Bystander Signals from Irradiated Human Mesenchymal Stromal Cells Mainly Localize in the 10–100 kDa Fraction of Conditioned Medium
by: Vanessa Kohl, et al.
Published: (2021-04-01) -
Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
by: Pedro M. Folegatti, et al.
Published: (2021-03-01)